Drug Linked to Hepatitis C Cure Has Atlanta Ties
MMG faculty member, Dr. Raymond Schinazi, was recently featured on WABE, Atlanta's NPR Station.
A federal Food and Drug Administration panel Friday recommended approving a new drug that, in combination with other treatments, helps to effectively stop hepatitis C. The drug, Sofosbuvir, has ties to Atlanta.
"Finally, my baby is becoming an adult, and now it's going to be used by a lot of people and save a lot of lives," says Emory University's Dr. Raymond Schinazi, who helped develop the drug.
While treatments for hepatitis C have been on the market for a few years, the combination of Simeprevir and Sofosbuvir with another drug is considered to be the first cure with nearly 100%-effectiveness.
And it all happened very quickly, at least in terms of drug development.
“I don’t think many drugs have been discovered and developed in six years from start-to-finish. That’s amazing," says Dr. Schinazi.
Click here to view the full article.